Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Walker: bNabs after Infection and Immunization |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2015-04-02 |
| Study Made Public: | 2016-02-16 |
Title
Tier 1 and Tier 2 neutralization evaluation of plasma samples from 47 HIV+ individuals from an clinical HIV-1 observation cohort in Germany
Description
CAVD 485 is an immunogenicity study of broadly neutralizing antibodies.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.